Lupin Pharmaceuticals, Inc. - U.S.A.

• Lupin reported a standalone net loss of ₹59.1 million for Q2 FY27, contrasting with a consolidated net profit of ₹11.55 billion for the same period. • The Board declared a final dividend of ₹18 per